Unraveling the Concealed Transcriptomic Landscape of PTEN in Human Malignancies

Overview

Journal Curr Genomics

Publisher Bentham Science Publishers

Date 2024 Jan 3

PMID 38169628

Authors

Michaela A Boti

Panagiotis G Adamopoulos

Dido Vassilacopoulou

Andreas Scorilas

Affiliations

Soon will be listed here.

Abstract

Background: Phosphatase and tensin homolog, widely known as PTEN, is a major negative regulator of the PI3K/AKT/mTOR signaling pathway, involved in the regulation of a variety of important cellular processes, including cell proliferation, growth, survival, and metabolism. Since most of the molecules involved in this biological pathway have been described as key regulators in cancer, the study of the corresponding genes at several levels is crucial.

Objective: Although previous studies have elucidated the physiological role of PTEN under normal conditions and its involvement in carcinogenesis and cancer progression, the transcriptional profile of PTEN has been poorly investigated.

Methods: In this study, instead of conducting the "gold-standard" direct RNA sequencing that fails to detect less abundant novel mRNAs due to the decreased sequencing depth, we designed and implemented a multiplexed PTEN-targeted sequencing approach that combined both short- and long-read sequencing.

Results: Our study has highlighted a broad spectrum of previously unknown PTEN mRNA transcripts and assessed their expression patterns in a wide range of human cancer and non-cancer cell lines, shedding light on the involvement of PTEN in cell cycle dysregulation and thus tumor development.

Conclusion: The identification of the described novel PTEN splice variants could have significant implications for understanding PTEN regulation and function, and provide new insights into PTEN biology, opening new avenues for monitoring PTEN-related diseases, including cancer.

References

Leslie N, Dixon M, Schenning M, Gray A, Batty I . Distinct inactivation of PI3K signalling by PTEN and 5-phosphatases. Adv Biol Regul. 2013; 52(1):205-13. DOI: 10.1016/j.advenzreg.2011.09.010. View

Di Cristofano A, De Acetis M, Koff A, Cordon-Cardo C, Pandolfi P . Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse. Nat Genet. 2001; 27(2):222-4. DOI: 10.1038/84879. View

Leslie N, Downes C . PTEN function: how normal cells control it and tumour cells lose it. Biochem J. 2004; 382(Pt 1):1-11. PMC: 1133909. DOI: 10.1042/BJ20040825. View

Mighell T, Evans-Dutson S, ORoak B . A Saturation Mutagenesis Approach to Understanding PTEN Lipid Phosphatase Activity and Genotype-Phenotype Relationships. Am J Hum Genet. 2018; 102(5):943-955. PMC: 5986715. DOI: 10.1016/j.ajhg.2018.03.018. View

Perevalova A, Kobelev V, Sisakyan V, Gulyaeva L, Pustylnyak V . Role of Tumor Suppressor PTEN and Its Regulation in Malignant Transformation of Endometrium. Biochemistry (Mosc). 2022; 87(11):1310-1326. DOI: 10.1134/S0006297922110104. View

Lee J, Yang H, Georgescu M, Di Cristofano A, Maehama T, Shi Y . Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Cell. 1999; 99(3):323-34. DOI: 10.1016/s0092-8674(00)81663-3. View

Vanhaesebroeck B, Stephens L, Hawkins P . PI3K signalling: the path to discovery and understanding. Nat Rev Mol Cell Biol. 2012; 13(3):195-203. DOI: 10.1038/nrm3290. View

Denu J, Stuckey J, Saper M, Dixon J . Form and function in protein dephosphorylation. Cell. 1996; 87(3):361-4. DOI: 10.1016/s0092-8674(00)81356-2. View

Podsypanina K, Ellenson L, Nemes A, Gu J, Tamura M, Yamada K . Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc Natl Acad Sci U S A. 1999; 96(4):1563-8. PMC: 15517. DOI: 10.1073/pnas.96.4.1563. View

10.

Manning B, Cantley L . AKT/PKB signaling: navigating downstream. Cell. 2007; 129(7):1261-74. PMC: 2756685. DOI: 10.1016/j.cell.2007.06.009. View

11.

Wick R, Judd L, Holt K . Performance of neural network basecalling tools for Oxford Nanopore sequencing. Genome Biol. 2019; 20(1):129. PMC: 6591954. DOI: 10.1186/s13059-019-1727-y. View

12.

Stambolic V, Suzuki A, de la Pompa J, Brothers G, Mirtsos C, Sasaki T . Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell. 1998; 95(1):29-39. DOI: 10.1016/s0092-8674(00)81780-8. View

13.

Maehama T, Dixon J . The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem. 1998; 273(22):13375-8. DOI: 10.1074/jbc.273.22.13375. View

14.

Durrant T, Hutchinson J, Heesom K, Anderson K, Stephens L, Hawkins P . In-depth PtdIns(3,4,5)P signalosome analysis identifies DAPP1 as a negative regulator of GPVI-driven platelet function. Blood Adv. 2017; 1(14):918-932. PMC: 5726495. DOI: 10.1182/bloodadvances.2017005173. View

15.

Bonneau D, Longy M . Mutations of the human PTEN gene. Hum Mutat. 2000; 16(2):109-22. DOI: 10.1002/1098-1004(200008)16:2<109::AID-HUMU3>3.0.CO;2-0. View

16.

Pulido R . PTEN: a yin-yang master regulator protein in health and disease. Methods. 2015; 77-78:3-10. DOI: 10.1016/j.ymeth.2015.02.009. View

17.

Shen S, Zhang C, Ge M, Dong S, Xia L, He P . PTENα and PTENβ promote carcinogenesis through WDR5 and H3K4 trimethylation. Nat Cell Biol. 2019; 21(11):1436-1448. DOI: 10.1038/s41556-019-0409-z. View

18.

Li Y, He L, Zeng N, Sahu D, Cadenas E, Shearn C . Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) signaling regulates mitochondrial biogenesis and respiration via estrogen-related receptor α (ERRα). J Biol Chem. 2013; 288(35):25007-25024. PMC: 3757167. DOI: 10.1074/jbc.M113.450353. View

19.

Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang S . PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 1997; 275(5308):1943-7. DOI: 10.1126/science.275.5308.1943. View

20.

Zhang Z, Xin D, Wang P, Zhou L, Hu L, Kong X . Noisy splicing, more than expression regulation, explains why some exons are subject to nonsense-mediated mRNA decay. BMC Biol. 2009; 7:23. PMC: 2697156. DOI: 10.1186/1741-7007-7-23. View